Kamunting Street Capital Management’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-95,694
Closed -$633K 22
2023
Q4
$633K Hold
95,694
0.79% 15
2023
Q3
$766K Sell
95,694
-15,280
-14% -$142K 0.58% 21
2023
Q2
$1.12M Sell
110,974
-25,526
-19% -$261K 1.11% 13
2023
Q1
$1.45M Hold
136,500
1.85% 11
2022
Q4
$1.57M Buy
136,500
+6,500
+5% +$58.2K 2.49% 7
2022
Q3
$1.11M Buy
+130,000
New +$1.08M 1.82% 10

Other funds holding TELA

Kamunting Street Capital Management's TELA Position: Q1 2024 in Review

Kamunting Street Capital Management sold out of TELA Bio (TELA) in Q1 2024, closing a stake of 95,694 shares — an estimated $633K sold.

Kamunting Street Capital Management first reported a position in TELA in Q3 2022 and held it in 6 quarters. The position peaked at $1.57M in Q4 2022. 58 funds tracked by Wall St. Rank hold TELA as of Q1 2024.

  • Kamunting Street Capital Management reported no remaining TELA Bio position as of Q1 2024 after selling out during the quarter.
  • Kamunting Street Capital Management sold 95,694 TELA Bio shares in Q1 2024, an estimated $633K.
  • Kamunting Street Capital Management first reported a position in TELA Bio in Q3 2022 and held it in 6 quarters.
  • Kamunting Street Capital Management's TELA Bio position peaked at $1.57M in Q4 2022.
  • 58 funds tracked by Wall St. Rank held TELA Bio as of Q1 2024.

Based on Kamunting Street Capital Management's 13F filing for Q1 2024, filed 15 May 2024.